Stage IIC Rectal Cancer: Clinical Trials

14 trials for Stage IIC Rectal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 terminated, 1 withdrawn. 6 Not applicable, 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 6
Phase 14Completed 3, Terminated 1
Phase 23Completed 1, Terminated 1, Withdrawn 1

Follow Stage IIC Rectal Cancer: new trials by email Literature Review of Stage IIC Rectal Cancer trials Research Report on Stage IIC Rectal Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Best Practice, Laboratory Biomarker Analysis, Supportive Care - Acute Myeloid Leukemia, Brain Glioblastoma
Not applicableCompletedStanford University1282017-08-082025-01-24
Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment
Laboratory Biomarker Analysis, Regorafenib - Rectal Adenocarcinoma, Stage IIA Rectal Cancer
Phase 2WithdrawnRoswell Park Cancer Institute2015-03-012016-10-12
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer
intensity-modulated radiation therapy, fluorouracil, oxaliplatin - Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer
Phase 1CompletedVirginia Commonwealth University142014-12-042021-07-20
Programs to Support You During Chemotherapy (Pro-You)
Yoga Skills Training (YST), questionnaire administration, fatigue and depressive symptom assessment and management - Depressive Symptoms, Fatigue
Not applicableCompletedVanderbilt-Ingram Cancer Center32014-08-012015-06-23
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation
cytology specimen collection procedure, laboratory biomarker analysis - Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer
CompletedFox Chase Cancer Center432014-07-012024-05-02
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
educational intervention, telephone-based intervention, quality-of-life assessment - Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Not applicableCompletedCity of Hope Medical Center2002013-10-292026-10-01
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
bevacizumab, oxaliplatin, leucovorin calcium - Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum
Phase 2TerminatedUniversity of Southern California172013-08-022026-07-01
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
positron emission tomography, computed tomography, magnetic resonance imaging - Recurrent Colon Cancer, Recurrent Rectal Cancer
Not applicableCompletedCase Comprehensive Cancer Center152013-04-012021-05-18
Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
educational intervention, medical chart review - Adenocarcinoma of the Lung, Mucinous Adenocarcinoma of the Colon
Not applicableCompletedFox Chase Cancer Center14402013-01-012017-04-06
Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer
educational intervention, questionnaire administration, quality-of-life assessment - Stage I Colon Cancer, Stage I Rectal Cancer
Not applicableCompletedCity of Hope Medical Center302013-01-012013-12-18
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
trametinib, fluorouracil, radiation therapy - Recurrent Rectal Cancer, Stage IIA Rectal Cancer
Phase 1CompletedOhio State University Comprehensive Cancer Center192012-11-262023-09-18
Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
paricalcitol, radiation therapy, laboratory biomarker analysis - Mucinous Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer
Phase 1TerminatedWake Forest University Health Sciences22010-08-012018-07-02
Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
erlotinib hydrochloride, placebo, laboratory biomarker analysis - Adenomatous Polyp, Recurrent Colon Cancer
Phase 2CompletedNational Cancer Institute (NCI)452008-07-012015-01-06
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer
fluorouracil, oxaliplatin, radiation therapy - Adenocarcinoma of the Rectum, Mucinous Adenocarcinoma of the Rectum
Phase 1CompletedNational Cancer Institute (NCI)201999-05-012013-01-10

Narrower conditions

Rectal Neoplasms (14)  ·  Colonic Neoplasms (7)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Carcinoma, Renal Cell (2)  ·  Pancreatic Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Urinary Bladder Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Adenomatous Polyps (1)  ·  Bone Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Colorectal Neoplasms (1)  ·  Depression (1)  ·  Disease Progression (1)

Broader conditions

Digestive System Diseases (14)  ·  Digestive System Neoplasms (14)  ·  Gastrointestinal Diseases (14)  ·  Gastrointestinal Neoplasms (14)  ·  Intestinal Diseases (14)  ·  Intestinal Neoplasms (14)  ·  Neoplasms (14)  ·  Neoplasms by Site (14)  ·  Rectal Diseases (14)  ·  Colorectal Neoplasms (13)  ·  Colonic Diseases (7)  ·  Lung Diseases (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Respiratory Tract Diseases (4)

Interventions

Fluorouracil (5)  ·  Early Intervention, Educational (3)  ·  Leucovorin (3)  ·  Methods (3)  ·  Oxaliplatin (3)  ·  Radiation (3)  ·  Radiotherapy (3)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Bevacizumab (1)  ·  Erlotinib Hydrochloride (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Palliative Care (1)  ·  Practice Guidelines as Topic (1)  ·  Radiotherapy, Intensity-Modulated (1)

Sponsors

City of Hope Medical Center (2)  ·  Fox Chase Cancer Center (2)  ·  National Cancer Institute (NCI) (2)  ·  Case Comprehensive Cancer Center (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Roswell Park Cancer Institute (1)  ·  Stanford University (1)  ·  University of Southern California (1)  ·  Vanderbilt-Ingram Cancer Center (1)  ·  Virginia Commonwealth University (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (14)

Top investigators

Afsaneh Barzi (1)  ·  Betty Ferrell (1)  ·  Crystal Denlinger, MD (1)  ·  Daniel Haller (1)  ·  Emma C Fields, MD (1)  ·  George Yacoub, MD (1)  ·  Joshua Meyer (1)  ·  Manali Patel (1)  ·  Patrick Boland (1)  ·  Raj Paspulati, MD (1)  ·  Sameek Roychowdhury, MD (1)  ·  Stephanie Sohl (1)  ·  Timothy Morgan (1)  ·  Virginia Sun (1)

Results publications

PMID 32649004, PMID 34749008, PMID 35771552

NIH funding

N01CN35160 (1), P30CA006927 (1), P30CA014089 (1), P30CA016056 (1), P30CA016059 (1), P30CA068485 (1), U10CA021115 (1)